Psychiatric and Psychological Care Utilization Among Patients with Atopic Dermatitis, Hidradenitis Suppurativa, and Psoriasis: Insights from a Propensity-Matched Real-World Cohort Analysis - Takeaways - MDSpire

Psychiatric and Psychological Care Utilization Among Patients with Atopic Dermatitis, Hidradenitis Suppurativa, and Psoriasis: Insights from a Propensity-Matched Real-World Cohort Analysis

  • By

  • Marta Szepietowska

  • Piotr K. Krajewski

  • Przemyslaw Pacan

  • Anna Wojas-Pelc

  • Jacek C. Szepietowski

  • Andrzej K. Jaworek

  • March 3, 2026

Share

  • 1

    Patients with atopic dermatitis, hidradenitis suppurativa, and psoriasis utilize psychiatric care significantly more than matched controls.

  • 2

    Psychotherapy is notably higher in atopic dermatitis patients, while pharmacotherapy is most prevalent in hidradenitis suppurativa.

  • 3

    Women generally show greater utilization of psychiatric care in atopic dermatitis, with disease-specific patterns in hidradenitis suppurativa and psoriasis.

  • 4

    The study highlights the need for integrated management strategies that address both mental health and dermatologic treatment.

  • 5

    Real-world data on psychiatric care utilization among chronic inflammatory skin disease patients is limited, necessitating further research.

Original Source(s)

Psychiatric and Psychological Care Utilization Among Patients with Atopic Dermatitis, Hidradenitis Suppurativa, and Psoriasis: Insights from a Propensity-Matched Real-World Cohort Analysis

  • by Marta Szepietowska, Piotr K. Krajewski, Przemyslaw Pacan, Anna Wojas-Pelc, Jacek C. Szepietowski, Andrzej K. Jaworek

  • March 3, 2026

Related Content

The Role of Inflammatory Biomarkers in Disease Severity and Treatment Response across Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa—A Narrative Review

Does TYK2/JAK1 Show Potential in Inflammatory Diseases?

Investigational inhibitor was not associated with treatment-related serious adverse events and produced biomarker changes consistent with pathway inhibition in healthy volunteers.

Immunobiological Therapy in Moderate-to-Severe Psoriasis: A Retrospective Cohort Study Investigating the Effects of Inadequate Therapeutic Compliance on Drug Survival